Growth for over-the-counter (OTC) drugs is strongest in emerging economies but is an $89 billion opportunity in the US, according to data from The Nielsen Company and Nicholas Hall and Company.
(more…)
↧
OTC Growth Presents $89B US Opportunity
↧